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Lymphocytic 
Choriomeningitis 
with Severe 
Manifestations, 
Missouri, USA
To the Editor: Lymphocytic 
choriomeningitis virus (LCMV) is an 
arenavirus maintained zoonotically 
in house mice (Mus musculus) and 
may also be carried by pet rodents, 
especially hamsters (1–3). Infection 
of healthy humans usually results in 
nonspeciﬁ  c febrile illness. However, 
LCMV infection can cause severe 
symptoms, including aseptic 
meningitis (4).
Early data suggested <8% of 
central nervous system manifestations 
of viral etiology were caused by 
LCMV (5). In contrast, in a more 
recent study of 91 cases of encephalitis 
among persons with potential rodent 
contact, LCMV was not detected (6). 
We describe 2 recent unrelated LCMV 
infections with central nervous system 
manifestations, which were associated 
with rodent exposures, as a reminder 
that LCMV should be considered 
in cases of aseptic meningitis of 
unknown etiology.
In July 2008, an 89-year-old man 
in Missouri, USA, with a history of 
hypertension received a prescription 
for metolazone and was given 
methotrexate (2.5 mg orally, 3×/wk) 
because of a pharmacy error. Two 
weeks later, he showed confusion, 
speech difﬁ   culty, and had a fever. 
When hospitalized 3 weeks after 
symptom onset, the patient was drowsy 
but able to answer questions and 
had a supple neck, plantar responses 
in extension, and a temperature of 
38.8°C. Methotrexate treatment was 
then stopped.
Routine laboratory test results 
were within reference ranges, with 
the exception of a serum aspartate 
aminotransferase level of 92 U/L 
(reference range 0–37 U/L) and an 
alanine aminotransferase level of 78 
U/L (reference range 0–65 U/L). Two 
blood cultures were sterile, a chest 
radiograph showed cardiomegaly, and 
cranial computed tomography without 
contrast showed moderate cerebral 
atrophy.
The patient was empirically 
given intravenous ceftriaxone (1 g) 
and intravenous azithromycin (500 
mg, 1×/d for 7 days). Two days after 
he was hospitalized, cranial magnetic 
resonance imaging showed mild-
to-moderate, chronic, small vessel 
ischemia and involutional changes. 
Serologic test results for HIV and 
West Nile virus were negative. On the 
fourth hospital day, lumbar puncture 
yielded clear, colorless cerebrospinal 
ﬂ  uid (CSF) containing 1 erythrocyte 
and 98 leukocytes/high-powered ﬁ  eld 
(1% neutrophils, 95% lymphocytes, 
4% monocytes); protein level was 
127 mg/dL (reference range 15–45 
mg/dL), and glucose level was 40 
mg/dL (reference range 43–70 mg/
dL). CSF test results for bacteria, 
cryptococcal antigen, and herpes 
simplex virus (HSV) and PCR 
result for Borrelia burgdorferi were 
negative. CSF and serum submitted 
to the Centers for Disease Control and 
Prevention showed LCMV-speciﬁ  c 
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immunoglobulin (Ig) M titers (serum 
6,400, CSF 1,280); IgG was not 
detected. Virus was not isolated.
The patient’s son-in-law reported 
that mice had been trapped in the 
patient’s home during the previous 
winter. The patient was treated 
supportively and discharged from the 
hospital 30 days after admission. Six 
weeks after discharge, the patient was 
well, without residual neurologic or 
cognitive deﬁ  cits.
In November, 2010, a 34-year-old 
woman in Missouri was hospitalized 
with a 1-day history of progressive 
headache, neck pain, photophobia, 
nausea, and vomiting. She had a history 
of asthma and migraine headaches and 
had twice undergone surgical repair of 
congenital heart defects in childhood. 
She was alert and cooperative, her neck 
was supple, results of a neurologic 
examination were normal, and her 
temperature was 38.6°C.
Laboratory studies showed a 
hemoglobin level of 11.0 g/dL, a 
hematocrit of 33.1%, a peripheral 
leukocyte count of 9,600 cells/
mm3, a platelet count of 308,000/
mm3, a serum creatinine level of 0.7 
mg/dL, and normal liver functions. 
A chest radiograph showed mild 
interstitial changes. Cranial computed 
tomography without contrast showed 
normal results. Lumbar puncture 
showed hazy, colorless CSF, no 
erythrocytes, 544 leukocytes/high-
powered  ﬁ   eld (11% neutrophils, 
84% lymphocytes, 5% monocytes), 
a protein level of 122 mg/dL, and a 
glucose level of 56 mg/dL. Results of 
Gram staining; bacterial culture; and 
tests for enterovirus, HSV-1, HSV-2 
(PCR), and West Nile virus (IgM and 
IgG) were negative.
The patient was empirically given 
a 7-day course of ceftriaxone (2 g 
intravenously 1×/d) and vancomycin 
(1 g intravenously every 12 hours). 
CSF submitted to the Centers for 
Disease Control and Prevention was 
positive for LCMV by PCR and virus 
isolation. LCMV-speciﬁ   c IgM (titer 
1,280) was detected; IgG was not 
detected. The patient had observed 
mice in her home 3 months before 
hospitalization, although she did not 
recall any direct contact with them. Her 
condition improved with supportive 
therapy and she was released.
These patient observations under-
score the potential for severe 
manifestations of LCMV infection. 
Neurologic manifestations may 
mimic those of infections with other 
viruses, including HSV-1, HSV-
2, enteroviruses, and arboviruses, 
necessitating speciﬁ  c  diagnostic 
tests for identiﬁ   cation of the cause, 
particularly in patients who report 
recent contact with wild or pet rodents.
The ubiquitous nature of the 
LCMV reservoir and documented 
infections in numerous localities in 
the United States and internationally 
imply widespread geographic risk for 
LCMV infection (7). Serosurveys in 
the southern and eastern United States 
have indicated previous infection in 
≈3%–5% of persons (1,8). However, 
recent data from upstate New York 
indicated a seroprevalence <1% (9). 
Thus, the risk for LCMV infection can 
be minimized by active exclusion and 
trapping of rodents in the home and 
avoidance of pet rodents.
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